Two Partners Come Together to Manufacture Gene Therapy for RPGRIP1-Related Vision Disorders
According to a story from World Pharma Today, Andelyn Biosciences, Inc., which is a gene therapy Contract Development and Manufacturing Organization (CDMO), has recently struck a partnership with Odylia Therapeutics,…